Present and future of bronchopulmonary dysplasia
L Bonadies, P Zaramella, A Porzionato… - Journal of clinical …, 2020 - mdpi.com
Bronchopulmonary dysplasia (BPD) is the most common respiratory disorder among infants
born extremely preterm. The pathogenesis of BPD involves multiple prenatal and postnatal …
born extremely preterm. The pathogenesis of BPD involves multiple prenatal and postnatal …
Bronchopulmonary Dysplasia–Associated Pulmonary Hypertension: An Updated Review
A El-Saie, NP Varghese, MK Webb, N Villafranco… - Seminars in …, 2023 - Elsevier
Bronchopulmonary dysplasia (BPD) is the leading cause of chronic lung disease in infants
and the commonest complication of prematurity. Advances in respiratory and overall …
and the commonest complication of prematurity. Advances in respiratory and overall …
Stem-cell therapy for bronchopulmonary dysplasia (BPD) in newborns
Premature newborns are at a higher risk for the development of respiratory distress
syndrome (RDS), acute lung injury (ALI) associated with lung inflammation, disruption of …
syndrome (RDS), acute lung injury (ALI) associated with lung inflammation, disruption of …
Exosome therapeutics for lung regenerative medicine
Exosomes are 30 to 100 nm extracellular vesicles that are secreted by many cell types.
Initially viewed as cellular garbage with no biological functions, exosomes are now …
Initially viewed as cellular garbage with no biological functions, exosomes are now …
Mesenchymal stem cell-derived extracellular vesicles prevent experimental bronchopulmonary dysplasia complicated by pulmonary hypertension
M Sharma, MA Bellio, M Benny… - Stem cells …, 2022 - academic.oup.com
Mesenchymal stem cell (MSC) extracellular vesicles (EVs) have beneficial effects in
preclinical bronchopulmonary dysplasia and pulmonary hypertension (BPD-PH) models …
preclinical bronchopulmonary dysplasia and pulmonary hypertension (BPD-PH) models …
Proposed mechanisms of targeting COVID-19 by delivering mesenchymal stem cells and their exosomes to damaged organs
With the outbreak of coronavirus disease (COVID-19) caused by novel severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), the world has been facing an …
respiratory syndrome coronavirus 2 (SARS-CoV-2), the world has been facing an …
Effects of mesenchymal stromal cell-derived extracellular vesicles in lung diseases: current status and future perspectives
H Guo, Y Su, F Deng - Stem cell reviews and reports, 2021 - Springer
Mesenchymal stromal cells (MSCs) as a kind of pluripotent adult stem cell have shown great
therapeutic potential in relation to many diseases in anti-inflammation and regeneration. The …
therapeutic potential in relation to many diseases in anti-inflammation and regeneration. The …
[HTML][HTML] Imaging drug delivery to the lungs: Methods and applications in oncology
Direct delivery to the lung via inhalation is arguably one of the most logical approaches to
treat lung cancer using drugs. However, despite significant efforts and investment in this …
treat lung cancer using drugs. However, despite significant efforts and investment in this …
A review of placenta and umbilical cord-derived stem cells and the immunomodulatory basis of their therapeutic potential in bronchopulmonary dysplasia
Bronchopulmonary dysplasia (BPD) is a devastating lung disorder of preterm infants as a
result of an aberrant reparative response following exposures to various antenatal and …
result of an aberrant reparative response following exposures to various antenatal and …
Fighting the war against COVID-19 via cell-based regenerative medicine: lessons learned from 1918 Spanish flu and other previous pandemics
YJ Park, J Farooq, J Cho, N Sadanandan… - Stem cell reviews and …, 2021 - Springer
The human population is in the midst of battling a rapidly-spreading virus—Severe Acute
Respiratory Syndrome Coronavirus 2, responsible for Coronavirus disease 2019 or COVID …
Respiratory Syndrome Coronavirus 2, responsible for Coronavirus disease 2019 or COVID …